Recent News

• 04.23.2025 - Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET
• 04.23.2025 - Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET
• 04.14.2025 - Soleno Therapeutics Announces VYKAT(TM) XR Launch
• 04.14.2025 - Soleno Therapeutics Announces VYKAT(TM) XR Launch

Recent Filings

• 04.22.2025 - DEF 14A Other definitive proxy statements
• 04.22.2025 - ARS Annual Report to Security Holders
• 04.22.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.18.2025 - 8-K Current report
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 144 Report of proposed sale of securities
• 03.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - 4 Statement of changes in beneficial ownership of securities